R Kent Jr McGaughy
CIK 1402856 · last filed 2025-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$65.09M
Companies
5
Total Filings
46
Lifetime Open-Market Net
$65.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TIL | Director | 8,218,467 | $7.92 | $65.09M | $9.00M | 7 | 2025-05-29 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Director | 0 | $172.36 | $0 | $46.76M | 29 | 2023-09-26 |
| Apollo Endosurgery, Inc. (APEN) Delisted | Director | 0 | $10.00 | $0 | $10.02M | 8 | 2023-04-04 |
| Apollo Endosurgery, Inc. (LPTN) Delisted | Director | 36,608 | — | — | $0 | 1 | 2016-12-30 |
| GTOP | Director | — | $48.03 | — | $0 | 1 | 2007-06-13 |
Recent Filings · Page 2 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-25 | TIL | Grant (A) | — | $0 | EDGAR |
| 2022-03-17 | TIL | Other (J) | −260,323 | $0 | EDGAR |
| 2022-01-05 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-19 | Apollo Endosurgery, Inc. (APEN) Delisted | Buy (P) | +683,871 | $5.30M | EDGAR |
| 2021-06-14 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-25 | TIL | Mixed | +8,478,790 | $9.00M | EDGAR |
| 2021-03-22 | TIL | Grant (A) | — | $0 | EDGAR |
| 2020-12-29 | REATA PHARMACEUTICALS INC (RETA) Delisted | Other (J) | −166,666 | $0 | EDGAR |
| 2020-07-21 | Apollo Endosurgery, Inc. (APEN) Delisted | Buy (P) | +1,780,000 | $2.23M | EDGAR |
| 2020-06-22 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.